文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

提高蒙特利尔认知评估对识别中风后认知障碍的诊断准确性。

Improving diagnostic accuracy of the Montreal Cognitive Assessment to identify post-stroke cognitive impairment.

机构信息

Department of Neurology, University Hospital, Inselspital, University of Bern, Freiburgstr. 16, 3010, Bern, Switzerland.

Graduate School of Health Sciences, University of Bern, Bern, Switzerland.

出版信息

Sci Rep. 2024 Aug 29;14(1):20125. doi: 10.1038/s41598-024-71184-x.


DOI:10.1038/s41598-024-71184-x
PMID:39209968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11362592/
Abstract

Given advantages in reperfusion therapy leading to mild stroke, less apparent cognitive deficits can be overseen in a routine neurological examination. Despite the widespread use of the Montreal Cognitive Assessment (MoCA), age- and education-specific cutoffs for the detection of post-stroke cognitive impairment (PSCI) are not established, hampering its valid application in stroke. We aimed to establish age- and education-specific MoCA cutoffs to better discriminate patients with and without acute PSCI. Patients with acute ischemic stroke underwent the MoCA and a detailed neuropsychological assessment. PSCI was defined as a performance < - 1.5 SD in ≥ 2 cognitive domains. As secondary data analysis, the discriminant abilities of the MoCA-score (not adding + 1 as correction for ≤ 12 years of education, YoE) cutoffs were automatically derived based on Youden Index and evaluated by receiver operating characteristic analyses across age- (< 55, 55-70, > 70 years old) and education-specific (≤ 12 and > 12 YoE) groups. 351 stroke patients (67.4 ± 14.1 years old; 13.1 ± 2.8 YoE) underwent the neuropsychological assessment 2.7 ± 2.0 days post-stroke. The original MoCA cutoff < 26 falsely classified 26.2% of examined patients, with poor sensitivity in younger adults (34.8% in patients < 55 years > 12 YoE) and poor specificity in older adults (55.0%, in > 70 years ≤ 12 YoE). By maximizing both sensitivity and specificity, the optimal MoCA cutoffs were: (i) < 28 in patients aged < 55 with > 12 YoE (sensitivity = 69.6%, specificity = 77.8%); (ii) < 22 and < 25 in patients > 70 years with ≤ 12 and > 12 YoE (sensitivity = 61.6%, specificity = 90.0%; sensitivity = 63.3%, specificity = 84.0%, respectively). In other groups the optimal MoCA cutoff was < 26. Age and education level should be considered when interpreting MoCA-scores. Though new age- and education-specific cutoffs demonstrated higher discriminant ability for PSCI, their performance in young stroke and adults with higher education level was low due to ceiling effects and MoCA subtests structure, and cautious interpretation in these patients is warranted.Trial registration: ClinicalTrials.gov Identifier: NCT05653141.

摘要

鉴于再灌注治疗在轻度中风中的优势,在常规神经系统检查中可能会忽略不太明显的认知缺陷。尽管蒙特利尔认知评估(MoCA)应用广泛,但针对中风后认知障碍(PSCI)的年龄和教育特定截断值尚未确定,这阻碍了其在中风中的有效应用。我们旨在建立年龄和教育特定的 MoCA 截断值,以更好地区分急性 PSCI 患者和非 PSCI 患者。急性缺血性中风患者接受了 MoCA 和详细的神经心理学评估。PSCI 定义为在至少 2 个认知领域的表现 < -1.5 SD。作为二次数据分析,根据约登指数自动推导了 MoCA 评分(不添加 + 1 作为对 ≤ 12 年教育的校正,YoE)截断值的判别能力,并通过在年龄(< 55、55-70、> 70 岁)和教育特定(≤ 12 和 > 12 YoE)组内进行的接收者操作特征分析进行评估。351 名中风患者(67.4±14.1 岁;13.1±2.8 YoE)在中风后 2.7±2.0 天接受了神经心理学评估。原始 MoCA 截断值 < 26 错误地分类了 26.2%的检查患者,在年轻成年人中的敏感性较差(34.8%在患者 < 55 岁 > 12 YoE),在老年成年人中的特异性较差(55.0%,在 > 70 岁 ≤ 12 YoE)。通过最大限度地提高敏感性和特异性,最佳的 MoCA 截断值为:(i)在 > 12 YoE 的< 55 岁患者中 < 28(敏感性 = 69.6%,特异性 = 77.8%);(ii)在 ≤ 12 和 > 12 YoE 的 > 70 岁患者中 < 22 和 < 25(敏感性 = 61.6%,特异性 = 90.0%;敏感性 = 63.3%,特异性 = 84.0%)。在其他组中,最佳 MoCA 截断值为 < 26。解释 MoCA 评分时应考虑年龄和教育水平。尽管新的年龄和教育特定截断值对 PSCI 具有更高的判别能力,但由于天花板效应和 MoCA 子测试结构,年轻中风患者和接受高等教育的成年人的表现较差,因此在这些患者中需要谨慎解释。

试验注册:ClinicalTrials.gov 标识符:NCT05653141。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e45/11362592/5c4f827c9de4/41598_2024_71184_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e45/11362592/5c4f827c9de4/41598_2024_71184_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e45/11362592/5c4f827c9de4/41598_2024_71184_Fig1_HTML.jpg

相似文献

[1]
Improving diagnostic accuracy of the Montreal Cognitive Assessment to identify post-stroke cognitive impairment.

Sci Rep. 2024-8-29

[2]
Prediction of post-stroke cognitive impairment by Montreal Cognitive Assessment (MoCA) performances in acute stroke: comparison of three normative datasets.

Aging Clin Exp Res. 2022-8

[3]
Diagnostic test accuracy of the Montreal Cognitive Assessment in the detection of post-stroke cognitive impairment under different stages and cutoffs: a systematic review and meta-analysis.

Neurol Sci. 2018-2-9

[4]
Comparative Study of Two Short-Form Versions of the Montreal Cognitive Assessment for Screening of Post-Stroke Cognitive Impairment in a Chinese Population.

Clin Interv Aging. 2020-6-18

[5]
Effects of Normative Adjustments to the Montreal Cognitive Assessment.

Am J Geriatr Psychiatry. 2018-9-21

[6]
Development and validation of a clinical model (DREAM-LDL) for post-stroke cognitive impairment at 6 months.

Aging (Albany NY). 2021-9-10

[7]
Post-stroke cognitive impairment remains highly prevalent and disabling despite state-of-the-art stroke treatment.

Int J Stroke. 2024-10

[8]
Comparison of the Mini-Mental State Examination and Montreal Cognitive Assessment executive subtests in detecting post-stroke cognitive impairment.

Geriatr Gerontol Int. 2017-7-4

[9]
MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke.

Stroke. 2011-12-8

[10]
Validity of the MoCA as a cognitive screening tool in epilepsy: Are there implications for global care and research?

Epilepsia Open. 2024-8

引用本文的文献

[1]
MoCA and MMSE for the detection of post-stroke cognitive impairment: a comparative diagnostic test accuracy systematic review and meta‑analysis.

J Neurol. 2025-5-18

[2]
Predictive value of circulating inflammatory biomarkers for early-onset post-stroke cognitive impairment: a prospective cohort study.

Front Neurol. 2025-4-24

[3]
Blood biomarkers for vascular cognitive impairment based on neuronal function: a systematic review and meta-analysis.

Front Neurol. 2025-2-7

本文引用的文献

[1]
Post-stroke cognitive impairment remains highly prevalent and disabling despite state-of-the-art stroke treatment.

Int J Stroke. 2024-10

[2]
Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization-Lancet Neurology Commission.

Lancet Neurol. 2023-12

[3]
Domain-specific cognitive impairment 6 months after stroke: The value of early cognitive screening.

Int J Stroke. 2024-3

[4]
Which cutoff value of the Montreal Cognitive Assessment should be used for post-stroke cognitive impairment? A systematic review and meta-analysis on diagnostic test accuracy.

Int J Stroke. 2023-10

[5]
Comparison of Oxford Cognitive Screen and Montreal Cognitive Assessment feasibility in the stroke unit setting. A pilot study.

Cereb Circ Cogn Behav. 2021-7-4

[6]
Diverging Temporal Trends in Stroke Incidence in Younger vs Older People: A Systematic Review and Meta-analysis.

JAMA Neurol. 2022-10-1

[7]
Prediction of post-stroke cognitive impairment by Montreal Cognitive Assessment (MoCA) performances in acute stroke: comparison of three normative datasets.

Aging Clin Exp Res. 2022-8

[8]
European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment.

Eur Stroke J. 2021-9

[9]
Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

Lancet Neurol. 2021-10

[10]
Montreal Cognitive Assessment for the detection of dementia.

Cochrane Database Syst Rev. 2021-7-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索